Codix Pharma

What Codix Pharma does

Codix Pharma Limited is a privately held Nigerian pharmaceutical and health-tech company headquartered in Lagos, founded in 2002 with active operations commencing in March 2008. The company is organized under the Codix Group with two wholly-owned operating subsidiaries: Colexa Biosensor Limited, which operates the first In-Vitro Diagnostics (IVD) factory in Sub-Saharan Africa manufacturing the NAFDAC-registered OnPoint Blood Glucose Meter and Strips under ISO 13485:2016 certification, and Codix Bio Limited, which operates a WHO Health Technology Access Pool (HTAP) partner factory in Sagamu producing rapid diagnostic test kits for HIV, Malaria, and Hepatitis B and C at a stated capacity of 147 million+ test kits annually. Codix distributes the SD Biosensor portfolio of WHO-prequalified rapid diagnostic tests (Standard Q HIV, HIV/Syphilis Combo, HCV, Malaria Pf, Malaria Pf/Pan) and the Standard M10 point-of-care molecular diagnostic system approved by the Medical Laboratory Science Council of Nigeria (MLSCN).

The company's revenue model spans four streams: hardware sales of point-of-care diagnostic devices and rapid test kits to hospitals, laboratories, and diagnostic centers; consumer health products (wellness supplements and chronic illness management items); local manufacturing and packaging services for WHO-prequalified diagnostic kits; and professional training services delivered through Codix Academy in partnership with MLSCN and Olabisi Onabanjo University (OOU). Its go-to-market is sales-led, combining direct B2B sales to healthcare facilities, B2G engagement with Nigerian federal and state health programs under the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), and West African regional export through subsidiaries. Customer segments include healthcare facilities (hospitals, labs, primary care), patients with chronic cardiometabolic conditions, government health programs, and academic institutions.

Underlying technology centers on biosensor-based point-of-care diagnostics, lateral flow immunoassays, and fluorescence immunoassay (FIA) analyzers - sourced from SD Biosensor and now locally manufactured under HTAP sublicensing. Codix has no AI/ML capabilities disclosed; its competitive differentiation rests on regulatory approvals (WHO PQ, NAFDAC, MLSCN), local manufacturing scale, ISO certifications, and government/donor procurement access rather than proprietary algorithms. Management is led by Group Managing Director/CEO Sammy Ogunjimi, with Mary Ogangwu as COO and Enitan Odeyemi as Director of Business Development.

Name

Codix Pharma

Legal name

Codix Pharma Limited

Website

https://codixpharma.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Codix Pharma is a Nigerian pharmaceutical and health-tech company that manufactures and distributes point-of-care diagnostic devices and WHO-prequalified rapid test kits for cardiometabolic and infectious diseases, serving hospitals, laboratories, government health programs, and chronic disease patients across West Africa.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical Preparation Manufacturing (325412)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

• In-vitro diagnostics manufacturing
• Point-of-care testing
• Rapid diagnostic kits
• Cardiometabolic diagnostics
• Pharmaceutical distribution

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialties Products (B2B): Sale of point-of-care diagnostic devices and testing equipment to healthcare facilities, hospitals, and laboratories. Includes blood glucose meters, strips, and rapid diagnostic test kits.
2. Consumer Health Products: Sale of consumer health product ranges including daily total wellness products, multivitamins, and supplements for disease prevention and chronic illness management.
3. Manufacturing Services: Local packaging and manufacturing of WHO prequalified rapid diagnostic test kits at the Colexa Biosensor facility, serving both domestic and international procurement requirements.
4. Training and Education Services: Codix Academy provides training programs for healthcare professionals and students through partnerships with universities and medical councils.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Codix Pharma manufactures and distributes point-of-care diagnostic devices and rapid diagnostic test kits for cardiometabolic and infectious diseases (diabetes, hypertension, HIV, Malaria, Hepatitis B/C), along with consumer wellness supplements. Through its subsidiaries Colexa Biosensor Limited and Codix Bio Limited, the company operates Nigeria's first ISO 13485-certified IVD factory and the first WHO HTAP-supported rapid diagnostic test kit manufacturing facility in Sub-Saharan Africa.

Product overview

Codix Pharma is an ISO 9001-2015 certified Nigerian pharmaceutical and health-tech company offering two broad product categories: Codix Specialties Products (point-of-care diagnostic devices for cardiometabolic diseases including diabetes, hypertension, and heart disease) and Consumer Health Products (daily wellness supplements and chronic illness management products). The company distributes a portfolio of SD Biosensor rapid diagnostic tests (WHO Prequalified for HIV, Malaria, Hepatitis C, and Syphilis) and the Standard M10 molecular diagnostic system. Through its subsidiary Colexa Biosensor Limited, Codix manufactures the OnPoint Blood Glucose Meter and Strips locally at its ISO 13485-certified IVD factory, and through another subsidiary Codix Bio, it produces rapid diagnostic test kits at a WHO HTAP-supported facility. Codix Academy provides training programmes in biosensors and nanotechnology alongside MLSCN and OOU. The company does not offer a public API.

Differentiator

Problem solved

Functional benefit

Brands

• Codix Specialties Products: Point-of-care devices for diagnosis, screening, and monitoring of cardiometabolic and related diseases
• Consumer Health Products
• Codix Charity Foundation
• Codix Academy
• Colexa Biosensor
• Codix Bio

Products and services

• OnPoint Blood Glucose Meter and Strips Blood glucose monitoring devices and test strips manufactured locally by Colexa Biosensor Limited in Nigeria. Evaluated, approved, and registered by NAFDAC, designed for patients with diabetes to support early detection and ongoing disease management.
• Standard Q HIV 1/2 Ab 3-Line Test WHO Prequalified rapid diagnostic test kit for HIV 1/2 antibody detection. Distributed by Codix Pharma in Nigeria and internationally procured by organizations such as PEPFAR, USAID, and the Global Fund.
• Standard Q HIV/Syphilis Combo Test WHO Prequalified rapid diagnostic combo test for simultaneous detection of HIV and Syphilis antibodies, procured by global health organizations for national screening programs.
• Standard Q HCV Ab Test WHO Prequalified rapid diagnostic test for Hepatitis C Virus antibody detection.
• Standard Q Malaria Ag Pf Test WHO Prequalified rapid diagnostic test for Plasmodium falciparum malaria antigen detection.
• Standard Q Malaria Ag Pf/Pan Test WHO Prequalified rapid diagnostic test for Plasmodium falciparum and Pan (vivax and other species) malaria antigen detection.
• Standard M10 Point-of-care MDx System Innovative point-of-care molecular diagnostic system by SD Biosensor, approved for use in Nigeria by the Medical Laboratory Science Council of Nigeria (MLSCN) following validation for sensitivity, specificity, and accuracy.
• SD Biosensor FIA Analyser Point-of-care fluorescence immunoassay analyser for rapid diagnostic testing, providing reliable accuracy, precision, and turnaround time with an expanding test menu suitable for medical laboratories.
• Codix Vitamin C+D Effervescent Tablet Effervescent vitamin supplement containing sorbitol, a low-calorie polyol (sugar-alcohol) that does not spike blood pressure and has non-carcinogenic properties, positioned as a sugar substitute for health-conscious consumers.
• Codix Academy Educational and training platform operated by Codix Pharma in partnership with the Medical Laboratory Science Council of Nigeria (MLSCN) and Olabisi Onabanjo University (OOU) for leadership excellence and biosensor technology training, with enrollment growing from 70+ to 300+ students within two years.

Quantifiable outcome

• Reduced diagnostic kit imports by enabling local WHO-prequalified packaging in Africa for the first time
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

15 partnerships are on record, tiered flagship, minor and core.

• World Health Organization (WHO)flagshipStrategic or Co-development Partner · 9 May 2025WHO selected Codix Bio as the first African manufacturing partner under the WHO Health Technology Access Pool (HTAP) programme. Through sublicensing agreement with SD Biosensor and Medicines Patent Pool, Codix Bio receives proprietary rights, technical know-how, and materials to legally develop and produce rapid diagnostic test kits. The facility is within WHO's technical support system for technology transfer and regulatory assistance.
• Medicines Patent Pool (MPP)flagshipStrategic or Co-development Partner · 9 May 2025Co-licensor with WHO and SD Biosensor for the WHO HTAP programme, providing sublicensing rights for rapid diagnostic test kit production in Africa.
• Lagos Food BankminorOthers · 1 June 2024Partnership for G.R.U.B (Giving Relief, Uniting Bellies) community engagement program, bringing relief to 500 children in low-cost primary schools.
• Lateef Jakande Leadership AcademyminorOthers · 1 June 2024Contribution to The Greater Health Project by donating innovative medical devices and cardio-metabolic drugs to Isheri Primary Healthcare Centre.
• Olabisi Onabanjo University (OOU)coreStrategic or Co-development Partner · 24 May 2024Partnership to introduce Biosensor and Nanotechnology Curriculum at OOU. Launched in 2024, the program graduated two cohorts of students within two years, growing from 70+ students to 300+ students. The collaboration bridges academia and industry by providing students exposure to real-world biosensor technology applications.
• Medical Laboratory Science Council of Nigeria (MLSCN)coreStrategic or Co-development Partner · 25 April 2024Collaboration to launch inaugural edition of Codix Academy training Leadership Excellence program for medical laboratory professionals.
• Headfort FoundationminorOthers · 1 January 2024Support for access to justice initiative for indigent Nigerians and innocent inmates in Nigerian prisons.
• SD BiosensorcoreTechnology or IntegrationGlobal in-vitro diagnostics manufacturer providing technology platform for rapid diagnostic test kit production. Codix Pharma distributes SD Biosensor products including FIA analysers and Standard Q rapid tests, and produces kits under WHO HTAP sublicensing agreement.
• Colexa Biosensor LimitedcoreTechnology or IntegrationSubsidiary of Codix Group operating as the first In-Vitro Diagnostics factory in Sub-Saharan Africa, manufacturing blood glucose meters, strips, and rapid diagnostic test kits.
• Stallion LaboratoriesminorChannel Partner/ Reseller/ DistributorPharmaceutical partner with logo displayed on Codix Pharma website.
• BioMedminorChannel Partner/ Reseller/ DistributorPharmaceutical partner with logo displayed on Codix Pharma website.
• MiCominorChannel Partner/ Reseller/ DistributorPharmaceutical partner with logo displayed on Codix Pharma website.
• BioMedomicsminorChannel Partner/ Reseller/ DistributorPharmaceutical partner with logo displayed on Codix Pharma website.
• Pharma ManufactureminorChannel Partner/ Reseller/ DistributorPharmaceutical partner with logo displayed on Codix Pharma website.
• Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC)coreStrategic or Co-development PartnerGovernment initiative led by Dr. Abdu Mukhtar, committed to increasing Nigeria's local pharmaceutical production to 70% of domestic consumption by 2030. Initiative signed Executive Order prioritizing local manufacturers in government procurement.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Cipla: Indian multinational pharmaceutical company with deep presence in African generics and HIV/antiretroviral therapy markets. Comparable as an emerging-market pharmaceutical manufacturer distributing cardiometabolic and infectious disease products through government and donor-funded procurement in Nigeria.
• Roche Diagnostics: World-leading IVD manufacturer with extensive cardiometabolic, infectious disease, and molecular diagnostics portfolios. Comparable through cobas and Accu-Chek product lines that compete in Nigerian hospital and laboratory channels.
• Hologic: Global diagnostics and women's health company with molecular diagnostic platforms (e.g., Panther, Aptima) that overlap with the SD Biosensor M10 molecular system Codix distributes. Comparable through HIV/STI diagnostic portfolio targeting similar laboratory customers.
• Mylan/Viatris: Global pharmaceutical company with significant cardiometabolic drug portfolio (antiretroviral and diabetes therapies) competing for the same hospital and government procurement budgets in Nigeria. Comparable as a pharmaceutical distributor-manufacturer addressing cardiometabolic and infectious disease categories in Africa.
• bioMérieux: French in vitro diagnostics company serving clinical and industrial microbiology, immunoassays, and molecular diagnostics markets. Comparable through laboratory and hospital-focused diagnostic solutions serving infectious disease testing customers in Africa.
• QuidelOrtho: US-based IVD manufacturer with point-of-care rapid diagnostic and immunoassay products. Comparable through rapid diagnostic test offerings targeting infectious disease screening in resource-limited and emerging market settings.
• Abbott Diagnostics: Global IVD and point-of-care diagnostics incumbent offering glucose monitoring, infectious disease testing, and rapid diagnostics across Africa. Comparable product categories including blood glucose meters and HIV/malaria RDTs that compete with Codix's portfolio.

Direct peers

• Wondfo Biotech: Chinese rapid diagnostic test manufacturer competing in HIV, malaria, and hepatitis RDT categories. Comparable as a WHO-prequalified RDT manufacturer targeting emerging markets with similar price-sensitive procurement dynamics.
• SD Biosensor: South Korean IVD manufacturer whose Standard Q rapid tests and FIA analysers Codix distributes in Nigeria and whose sublicensed technology underpins Codix Bio's HTAP programme. Directly comparable as a point-of-care diagnostics company with global footprint and similar product platform.

Regional players

• Aspen Pharmacare: South African-headquartered pharmaceutical manufacturer with a substantial presence across Sub-Saharan Africa. Comparable as an African pharmaceutical manufacturer pursuing import substitution and local production for cardiometabolic and infectious disease products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=L79Up9goDzQ
• Xx.com/Codix_Pharma
• Facebookfacebook.com/codixpharma

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Codix Pharma